This trial is evaluating whether ACTHAR Gel 80 units twice weekly. will improve 1 primary outcome and 4 secondary outcomes in patients with Cutaneous Sarcoidosis. Measurement will happen over the course of Between week 0 and week 12..
This trial requires 10 total participants across 2 different treatment groups
This trial involves 2 different treatments. ACTHAR Gel 80 Units Twice Weekly. is the primary treatment being studied. Participants will be divided into 2 treatment groups. There is no placebo group. The treatments being tested are in Phase 2 & 3 and have had some early promising results.
Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.
In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.